Laxmi Dental Limited has announced its audited consolidated financial results for the quarter and financial year ended March 31, 2026. The company recorded its highest-ever quarterly revenue of ₹739.5 Mn in Q4FY26, representing a growth of 21.9% year-on-year. Profit After Tax (PAT) for the quarter stood at ₹100.9 Mn, a significant increase of 136.1% compared to ₹42.7 Mn in the corresponding quarter of the previous year.

Financial Performance

EBITDA for the quarter stood at ₹135.0 Mn, an increase of 41.8% YoY, with an EBITDA margin of 18.3%. For the full financial year FY26, revenue grew by 16.2% YoY to ₹2,778.6 Mn, while PAT was ₹289.2 Mn. The company remains debt-free with a cash and bank balance including investments of around ₹99 crores.

Operational Highlights

Gross profit margins for Q4FY26 stood at 70.5%, showing a sequential improvement. Excluding scanner sales, the gross margins for the Core Dental Business remained steady at approximately 76.0%. The company noted that scanner sales, while low margin, are strategic and act as an enabler for future growth in the Dental Lab and Aligner business. The company sold 211 scanners in Q4FY26 and 1,009 units in FY26.

Margins during the quarter were affected by a half-quarter impact of 74 basis points on EBITDA due to higher US tariffs. ESOP expenses, which are non-cash in nature, amounted to ₹1.3 Mn in Q4FY26 compared to ₹18.3 Mn in Q4FY25. Additionally, a tax benefit of ₹13 Mn was recorded in Q4FY26 related to a one-time exceptional item on gratuity expense recognized in Q3FY26.

For the full year FY26, margins were impacted by multiple one-offs, including a 72 bps US Tariff impact and a one-time expense of ₹57.8 Mn due to changes in the labour code. The company also recognized a positive impact of ₹32.3 Mn from deferred tax credit as its US subsidiary became profitable in FY26.

Segment Performance

The Dental Laboratory business reported its highest-ever quarterly performance, delivering a robust 27% YoY growth driven by a recovery in domestic business and international operations. The Aligner Solutions business reported revenue of ₹18 Cr during the quarter. Within this segment, Bizdent, the clear aligner business, recorded an 11% YoY growth, while Vedia, the aligner raw material business, reported a revenue of ₹7 Cr.

Management representatives including Mr. Rajesh Khakhar, Mr. Sameer Merchant, and Mr. Dharmesh Dattani participated in the earnings call organized on May 22, 2026.

Laxmi Dental Limited has announced its audited consolidated and standalone financial results for the quarter and financial year ended March 31, 2026. The company reported quarterly revenue from operations of INR 722 million in Q4FY26, marking a 19.54% year-on-year increase over INR 604 million in Q4FY25. The Board of Directors approved the financial results at its meeting held on May 21, 2026, and the company subsequently submitted copies of newspaper advertisements published in the Financial Express (English) and Mumbai Lakshdeep (Marathi) on May 23, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Consolidated Financial Performance

For the financial year ended March 31, 2026, the company reported a consolidated net profit of INR 289.20 million. Total income for the year stood at INR 2,864.04 million, while revenue from operations increased to INR 2,778.60 million, a 16.2% rise from the previous year. EBITDA for the year was INR 434 million, with a margin of 15.6%. The following table summarises the key consolidated financial metrics for the quarter and full year:

Equity share capital stood at INR 109.92 million (face value ₹2 each), while consolidated reserves (excluding revaluation reserve) as shown in the audited balance sheet stood at INR 2,323.28 million for FY26, compared to INR 1,975.45 million in FY25.

Standalone Financial Performance

On a standalone basis, Laxmi Dental reported total income from operations of INR 557.36 million in Q4FY26, compared to INR 426.85 million in Q4FY25. For the full year FY26, standalone total income from operations stood at INR 2,085.56 million, against INR 1,712.44 million in FY25. The table below presents the key standalone financial metrics:

Standalone reserves (excluding revaluation reserve) stood at INR 2,360.58 million for FY26, compared to INR 2,117.45 million in FY25.

Operational Highlights and Segment Performance

The company achieved a gross profit margin of 70.5% in Q4FY26, with core dental business margins excluding scanner sales remaining steady at approximately 76.0%. Management noted that scanner sales, while lower margin, are strategic and act as enablers for future growth in the Dental Lab and Aligner businesses. The Dental Laboratory business reported its highest-ever quarterly performance with 27% year-on-year growth, driven by a recovery in domestic business and record international revenue. The Aligner Solutions business reported revenue of INR 180 million during the quarter, with the Bizdent clear aligner business witnessing an 11% year-on-year recovery. These segment-level gains underscore the company's diversified revenue base and its continued focus on expanding both domestic and international dental care markets.

Exceptional Items and One-Offs

Financial performance for the year was impacted by several one-off items. The company recorded a one-time expense of INR 57.8 million due to changes in the labour code. Additionally, ESOP expenses for FY26 stood at INR 52.6 million compared to INR 21.9 million in the previous year. The company also recorded a tax benefit of INR 13 million in Q4FY26 related to the gratuity expense recognised in Q3FY26. In the prior year, an exceptional item of INR 70.3 million was recorded pertaining to a gain on property sale.